Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Envista Holdings Corporation Common Stock (NVST) vs Roivant Sciences Ltd. Common Shares (ROIV) Price & Performance

Envista Holdings Corporation Common StockTrade
Roivant Sciences Ltd. Common SharesTrade

Price performance (Past 24H)

Key statistics

Envista Holdings Corporation Common Stock vs Roivant Sciences Ltd. Common Shares — how do they compare? Envista Holdings Corporation Common Stock trades at $22.57 (market cap $3.67B), while Roivant Sciences Ltd. Common Shares trades at $33.72 (market cap $24.99B). The key difference: Roivant Sciences Ltd. Common Shares is far larger — about 6.8× Envista Holdings Corporation Common Stock's market cap, and Roivant Sciences Ltd. Common Shares is trading nearer its 52-week high, Envista Holdings Corporation Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Envista Holdings Corporation Common Stock for 0 Days and Roivant Sciences Ltd. Common Shares for 3 Days on average.

NVSTROIV
Market Cap
$3.67B$24.99B
Volume
1,988,4354,711,562
Sector
HealthHealth
52-Week High
$30.26$41.81
52-Week Low
$18.95$16.99
Typical Hold Time
0 Days3 Days
Enterprise Value
$4.13B$21.25B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Envista Holdings Corporation Common Stock

No Aura AI signal available yet.

Roivant Sciences Ltd. Common Shares

Roivant Sciences (ROIV) trades at $33.35, down 3.58% on the day amid a bearish technical signal. The stock faces fundamental headwinds with a net loss of $172 million in 2025 and negative cash flow, though recent news highlights pipeline progress including positive Phase 2 data for mosliciguat in PH-ILD. Analyst sentiment remains strongly bullish with a consensus price target of $46.75.

The outlook hinges on clinical execution; upside exists if pipeline assets like LISRAYA launch successfully, but high cash burn and profitability challenges pose significant risks. Near-term price action is pressured, but long-term value depends on converting R&D into commercial success.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

NVST
100% Buy0% Sell
Avg holding period · 0 Days
ROIV
100% Buy0% Sell
Avg holding period · 3 Days

About Envista Holdings Corporation Common Stock

Envista Holdings Corporation is a global dental products company that develops, manufactures, and markets dental implants, orthodontic systems, and other consumables and equipment for dental professionals worldwide.

Read more on NVST →

About Roivant Sciences Ltd. Common Shares

Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.

Read more on ROIV →